Irish ayes: Lilly goes ahead with bioproduction expansion, adding 130 jobs

By Dan Stanton contact

- Last updated on GMT

Image: iStock/jamegaw
Image: iStock/jamegaw
Eli Lilly has confirmed it will build a three-story biomanufacturing facility at its site in Kinsale three months after rumours the project had been put on hold.

US drugmaker Eli Lilly sought permission from County Cork Council to construct a three-story facility housing an additional production line at its bioproduction site in Kinsale, Ireland back in October.

And today the firm confirmed the project has been approved, leading to a spike in jobs at the site.

“The site is expected to require up to 130 additional staff by 2020, and those manufacturing jobs will be a mix of operations and technical support staff,”​ Lilly spokesman Ger Kenny told Biopharma-Reporter.com.

He added a further 350 jobs will be required throughout the construction phase.

The confirmation comes three months after reports in both national and trade media saying the project had been placed on hold ahead of proposed​ changes to US tax laws will make pharmaceutical imports more expensive.

A Lilly spokeswoman at the time rebuffed this, telling us​ reports the investment had halted in response to the proposed changes were the result of “people writing what they want to write,”​ and the firm was yet to have made a decision on expanding the site.

While some media outlets have said the expansion will cost Lilly around €200m ($212m), Ger told us the firm is not confirming a figure for the investment at this point.”

Related news

Show more

Related products

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars